2026-01-12 01:23:44

Next week (January 12-16), there are several key dates in the financial markets and industry that may influence market momentum.

**January 12** is quite packed. In the morning, JPMorgan Chase's Healthcare Annual Conference will focus on the direction of innovative drugs, which provides guidance for the pharmaceutical sector. At the same time, the National Bureau of Statistics will release December's CPI and PPI data, two indicators that directly reflect consumer trends and cyclical industry performance, and are market focal points.

**January 13** the central bank will publish December's financial data, which involves liquidity and credit issuance in the banking system, crucial for pricing cyclical assets. Additionally, UBS will hold a Greater China seminar to analyze prospects for the A-share market and the AI sector.

**January 14** features a conference on liquid cooling technology for data centers and thermal management of AI chips. This event focuses on infrastructure development for computing power, and given the current surge in AI computing demand, it is worth following.

**January 16** concludes with two events: a conference on controlled nuclear fusion technology and industry development, focusing on long-term energy solutions; and a routine press conference by the China Securities Regulatory Commission, which will reveal signals regarding IPO and refinancing schedules, providing important references for the primary market and capital flows.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

9 Likes

Reward
9
3
Repost
Share

Comment

0/400

WalletDoomsDay

· 13h ago

Next week's event calendar, focus on the CPI data on January 12th, as that's the real market mover. Don't miss the AI chip conference; liquid cooling technology is likely to gain momentum. When the central bank's financial data is released, cyclical stocks will either take off or lie flat, depending on the data. Nuclear fusion, IPO pace, innovative medicines... it all looks lively, but as always, the data is king. The JPMorgan Healthcare Conference was just so-so; pharmaceutical stocks have already been through enough lessons in the past two years.

View OriginalReply0

JustHereForAirdrops

· 14h ago

Wait, is it another data-intensive week? CPI, PPI, central bank data all at once—can we slow down this pace...

View OriginalReply0

StakeTillRetire

· 14h ago

The CPI release on the 12th is probably going to be disappointing again. I already sold off the pharmaceutical sector a while ago. Now, I'm just waiting to see what the central bank says on the 13th.

View OriginalReply0